Company News Alert for Alda Pharmaceuticals

ALDA Products Available Through Esthetics Plus Retailers

VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 6, 2009) - ALDA Pharmaceuticals Corp. (TSX VENTURE:APH)(OTCBB:APCSF) ("the Company" or "ALDA") advises that its products are available through the outlets served by the Company's exclusive distributors to the spa and salon markets, Eastern Esthetics and LCN Canada - West.

A list of retailers is provided at:

www.lcn.ca/SalonsRetailers/Canada/ta...

A list of distributors is provided at:

www.lcn.ca/Distributors/LCNCanadianD...

The products distributed by Esthetics Plus include:

- T36(R) Disinfectant

- T36(R) Antiseptic Hand Sanitizer Gel

- T36(R) Disinfectant Cleaner CONCENTRATE

About ALDA Pharmaceuticals Corp.

ALDA is focused on the development of infection-control therapeutics derived from its patented T36(R) technology. The company trades on the TSX Venture Exchange under the symbol APH and on the OTC BB under the symbol APCSF.

Terrance G. Owen, Ph.D., MBA, President & CEO

ALDA Pharmaceuticals Corp.

Cautionary Note Regarding Forward-looking Statements: Information in this press release that involves ALDA's expectations, plans, intentions or strategies regarding the future are forward-looking statements that are not facts and involve a number of risks and uncertainties. ALDA generally uses words such as "outlook", "will", "could", "would", "might", "remains", "to be", "plans", "believes", "may", "expects", "intends", "anticipates", "estimate", "future", "plan", "positioned", "potential", "project", "remain", "scheduled", "set to", "subject to", "upcoming", and similar expressions to help identify forward-looking statements. The forward-looking statements in this release are based upon information available to ALDA as of the date of this release, and ALDA assumes no obligation to update any such forward-looking statements. Forward-looking statements believed to be true when made may ultimately prove to be incorrect. These statements are not guarantees of the future performance of ALDA and are subject to risks, uncertainties and other factors, some of which are beyond its control and may cause actual results to differ materially from current expectations.

FOR FURTHER INFORMATION PLEASE CONTACT:

Retail Sales

Eastern Esthetics (ON, QU, NB, NS, PE, NL)

902-450-2161

or

Retail Sales

LCN Canada - West (MN, SN, AB, BC, NW, YK)

780-462-2580

or

ALDA Pharmaceuticals Corp.

Peter Chen

Distribution & Sales Contact

604-521-8300 Ext. 3

604-521-8322 (FAX)

peter_chen@aldacorp.com

or

Distribution & Sales Contact

Scott Young

Investor Relations Contact

604-288-7222

syoung@freeformcom.com

www.aldacorp.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.